EXEMESTANE SCP exemestane 25 mg tablet blister pack

Pajjiż: Awstralja

Lingwa: Ingliż

Sors: Department of Health (Therapeutic Goods Administration)

Ingredjent attiv:

exemestane, Quantity: 25 mg

Disponibbli minn:

Southern Cross Pharma Pty Ltd

INN (Isem Internazzjonali):

Exemestane

Għamla farmaċewtika:

Tablet, sugar coated

Kompożizzjoni:

Excipient Ingredients: purified talc; microcrystalline cellulose; colloidal anhydrous silica; Acacia; mannitol; polysorbate 80; magnesium stearate; sucrose; titanium dioxide; crospovidone; ethanol; Shellac; white beeswax; Carnauba Wax

Rotta amministrattiva:

Oral

Unitajiet fil-pakkett:

30 tablets

Tip ta 'preskrizzjoni:

(S4) Prescription Only Medicine

Indikazzjonijiet terapewtiċi:

Sequential adjuvant treatment of oestrogen receptor positive early breast cancer in postmenopausal women who have received prior adjuvant tamoxifen therapy.,Treatment of oestrogen receptor positive advanced breast cancer in women with natural or induced postmenopausal status whose disease has progressed following antioestrogen therapy.

Sommarju tal-prodott:

Visual Identification: White to off-white, circular, biconvex, sugar-coated tablets; Container Type: Blister Pack; Container Material: PVC/PVDC/Al; Container Life Time: 3 Years; Container Temperature: Store below 30 degrees Celsius

L-istatus ta 'awtorizzazzjoni:

Registered

Data ta 'l-awtorizzazzjoni:

2011-10-06